LUV
33
-3
CSX
64
4
BEN
48
2
CMS
64
-3
CVX
40
2
GLW
68
4
EQT
50
6
PBI
53
-9
OI
50
7
USB
47
4
MAT
54
3
NWL
35
3
PRGO
46
-2
EQIX
62
3
COST
53
2
TGT
52
2
CF
60
3
UA
24
-9
AXP
69
2
PDCO
58
3
LUV
33
-3
CSX
64
4
BEN
48
2
CMS
64
-3
CVX
40
2
GLW
68
4
EQT
50
6
PBI
53
-9
OI
50
7
USB
47
4
MAT
54
3
NWL
35
3
PRGO
46
-2
EQIX
62
3
COST
53
2
TGT
52
2
CF
60
3
UA
24
-9
AXP
69
2
PDCO
58
3
Financhill
Back

908 Devices Vs. Perspective Therapeutics Industry Stock Comparison

Sell
49

MASS
908 Devices

Last Price:
3.68
Seasonality Move:
-26.92%
Sell
31

CATX
Perspective Therapeutics

Last Price:
13.74
Seasonality Move:
-10.19%
Sell
49
908 Devices (MASS) is a Sell

Is 908 Devices a Buy, Sell or Hold?

  • The current 908 Devices [MASS] share price is $3.84. The Score for MASS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • MASS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.47. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MASS Stock Price Chart

What is 908 Devices's stock price today?

  • The 908 Devices share price today is $3.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MASS is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

MASS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 45.4 Sell
Chaikin Money Flow: 13033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.13) Sell
Bollinger Bands (100): (4.18 - 6.18) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 42.96 Sell
Chaikin Money Flow: -538312 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.95 - 15.75) Sell
Bollinger Bands (100): (11.53 - 15.95) Sell

MASS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.61 Buy
20-day SMA: 3.76 Buy
50-day SMA: 4.51 Sell
200-day SMA: 6.26 Sell
8-day EMA: 3.68 Buy
20-day EMA: 3.81 Buy
50-day EMA: 4.33 Sell
200-day EMA: 5.84 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.46 Sell
20-day SMA: 14.98 Sell
50-day SMA: 13.73 Sell
200-day SMA: 11.27 Buy
8-day EMA: 14.11 Sell
20-day EMA: 14.44 Sell
50-day EMA: 13.95 Sell
200-day EMA: 11.5 Buy

908 Devices Earnings Growth & MASS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.11 per share, and an increase next year of $0.15 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

908 Devices Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):